BioengineeringCytotherapyPeer-reviewed
DNA-Dependent Protein Kinase Inhibitors PI-103 and Samotolisib Augment CRISPR/Cas9 Knockin Efficiency in Human T Cells
Emina Džafo, Morteza Hafezi, Greta Maria Paola Giordano Attianese…·Bernhard Gentner
This study shows that PI-103 and samotolisib enhance CRISPR/Cas9-mediated TCR knockin efficiency in human T cells without affecting viability or phenotype.
2 citations